Aditxt, Inc. Debt Instrument, Face Amount
Aditxt, Inc. (ADTX) had Debt Instrument, Face Amount of $18.78 thousand as of 2024-05-20, per its 10-Q filed 2025-05-15.
Financial Statements › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFaceAmount · last filed 2025-05-15
- 2024-05-20: Debt Instrument, Face Amount $18.78K.
- 2023-10-05: Debt Instrument, Face Amount $4.47M.
- 2023-09-30: Debt Instrument, Face Amount $1.04M.
- 2023-05-30: Debt Instrument, Face Amount $2.00M.
| Period end | Debt Instrument, Face Amount |
|---|---|
| 2024-05-20 | $18.78K 10-Q · filed 2025-05-15 |
| 2023-10-05 | $4.47M 10-K · filed 2025-03-31 |
| 2023-09-30 | $1.04M 10-Q · filed 2023-11-14 |
| 2023-05-30 | $2.00M 10-K · filed 2024-04-16 |
| 2023-04-04 | $1.06M 10-K · filed 2024-04-16 |
| 2019-03-21 | $10.00K 10-K · filed 2021-03-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Rafael Holdings, Inc. (RFL) | United States | $0.000B | -0.00 |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |